1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.2.1 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.2.1 Strengths of dPCR and qPCR
3.2.2 Application of Digital PCR Applications
3.2.3 Emerging Applications of Droplet Digital PCR
3.3 Industry Trends
3.4 Related Markets
3.4.1 In-Vitro Diagnostics
3.4.1.1 Industry trends
3.4.2 Liquid Biopsy Market
3.4.2.1 Trends of liquid biopsy market
3.4.3 Next-Generation Sequencing
3.4.3.1 Trends in the next-generation sequencing market
4 Market Outlook
4.1 Infectious Diseases detected by qPCR and ddPCR
4.2 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Evolution
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising demand for qPCR and dPCR in genetic and molecular testing
5.3.1.2 Increasing in private investment and funds
5.3.1.3 Increasing demand for biomarker-based tests
5.3.2 Restraints
5.3.2.1 Lack of skilled professionals
5.3.2.2 High cost of the qPCR and dPCR instruments
5.3.3 Opportunities
5.3.3.1 Growth of personalized medicines
5.3.3.2 Market expansion opportunities in emerging nations
5.3.4 DRO – Impact Analysis
5.4 Key Stakeholders
6 Technology Types: Market Size and Analysis
6.1 Overview
6.2 Digital Polymerase Chain Reaction
6.3 Real-Time/Quantitative Polymerase Chain Reaction
7 Product Types: Market Size and Analysis
7.1 Overview
7.2 Instrument
7.3 Reagents and Consumables
7.4 Software and Services
8 Application: Market Size and Analysis
8.1 Overview
8.2 Clinical Diagnostics
8.3 Biomedical Research
8.4 Others
9 End Users: Market Size and Analysis
9.1 Overview
9.2 Hospitals and Laboratories
9.3 Pharmaceutical Companies
9.4 Academics
9.5 Others
10 Regions: Market Size and Analysis
10.1 Overview
10.2 North America
10.2.1 Overview
10.3 Europe
10.3.1 Overview
10.4 Asia Pacific
10.4.1 Overview
10.5 Rest of the World
10.5.1 Overview
11 Competitive Landscape
12 Vendors Profile
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Overview
12.1.2 Business Units
12.1.3 Geographic Revenue
12.1.4 Business Focus
12.1.5 SWOT Analysis
12.1.6 Business Strategy
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Overview
12.2.2 Business Units
12.2.3 Geographic Revenue
12.2.4 Business Focus
12.2.5 SWOT Analysis
12.2.6 Business Strategies
12.3 Abbott Laboratories
12.3.1 Overview
12.3.2 Business Units
12.3.3 Geographic Revenue
12.3.4 Business Focus
12.3.5 SWOT Analysis
12.3.6 Business Strategies
12.4 Qiagen N.V.
12.4.1 Overview
12.4.2 Business Units
12.4.3 Geographic Revenue
12.4.4 Business Focus
12.4.5 SWOT Analysis
12.4.6 Business Strategies
12.5 Bio-Rad Laboratories
12.5.1 Overview
12.5.2 Business Units
12.5.3 Geographic Revenue
12.5.4 Business Focus
12.5.5 SWOT Analysis
12.5.6 Business Strategies
13 Companies to Watch for
13.1 Agilent Technologies Inc.
13.1.1 Overview
13.2 Promega Corp.
13.2.1 Overview
13.3 Eppendorf AG
13.3.1 Overview
13.4 BioMerieux S.A.
13.4.1 Overview
13.5 Merck KGaA
13.5.1 Overview
13.6 Danaher Corp. (Cepheid)
13.6.1 Overview
Annexure
Ø Acronyms